This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pharmacology
[{'content': 'Tildrakizumab was approved by FDA in 2018 for \nSelect and explain. \nA. Cystic fibrosis, B. Migraine, C. Hypeension, D. Psoriasis', 'role': 'user'}, {'content': 'Answer: D \nExplanation: Tildrakizumab was approved by FDA in 2018 to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy', 'role': 'assistant'}]